New and emerging therapies in cutaneous T-cell lymphoma [PDF]
Mycosis Fungoides (MF) is the most common cutaneous T-cell lymphoma that typically presents in the early phase as inflammatory erythematous patches or plaques, with epidermotropism as the histopathological hallmark of the disease.
Gabriele Roccuzzo +4 more
doaj +2 more sources
EXTRACORPOREAL PHOTOCHEMOTHERAPY IN THE TREATMENT OF TYPICAL AND ATYPICAL LICHEN PLANUS RUBRUM
Background: Lichen planus rubrum (LPR) belongs to the group of papulosquamous dermatoses. Pathophysiology of this most common lichenic dermatosis is related to autoimmune destruction of basal keratinocytes.
A. V. Molochkov +2 more
doaj +3 more sources
Rapid generation of maturationally synchronized human dendritic cells: contribution to the clinical efficacy of extracorporeal photochemotherapy. [PDF]
Berger C +15 more
europepmc +2 more sources
348 Immunomodulatory Effects of Extracorporeal Photochemotherapy in Systemic Sclerosis [PDF]
Zeher M +6 more
europepmc +2 more sources
Real-World Safety Data From the World Apheresis Association Registry for the Spectra Optia Apheresis System. [PDF]
ABSTRACT In this study we analyzed 12 years of adverse events, (AE) data from the World Apheresis Association, (WAA) Registry specific to the Spectra Optia Apheresis System. We queried WAA Registry data, (2012–2023) on apheresis procedures performed exclusively on the Spectra Optia Apheresis System.
Haubner A +13 more
europepmc +2 more sources
Immunomodulatory effects of extracorporeal photochemotherapy in systemic sclerosis
The aim of this study was to evaluate the clinical and immunomodulatory effects of extracorporeal photochemotherapy (ECP) in systemic sclerosis (SSc). We enrolled 16 patients with diffuse cutaneous SSc, who received 12 ECP treatments in total. After ECP treatments, the dermal thickness reduced and the mobility of joints improved.
Gábor Papp +6 more
openalex +4 more sources
Extracorporeal Photochemotherapy as a Challenging Treatment for Cutaneous T-Cell Lymphoma, Acute and Chronic Graft-versus-Host Disease, Organ Rejection and T-Lymphocyte-Mediated Autoimmune Diseases. [PDF]
Perseghin P.
europepmc +3 more sources
Use of Extracorporeal Photopheresis Treatment Over Time (2001-2023) in Alberta, Canada: A Retrospective Cohort Study. [PDF]
Health Science Reports, Volume 8, Issue 10, October 2025.
Girard L +7 more
europepmc +2 more sources
Mode of action, indications and recommendations on extracorporeal photopheresis (ECP)
Summary Extracorporeal photopheresis (ECP) has gained importance in the treatment of several diseases. Initially introduced as a new therapeutic modality for the treatment of patients with cutaneous T‐cell lymphoma, the indications for the use of ECP have expanded to include hematology and transplantation immunology.
Ara Cho +2 more
wiley +1 more source

